PGDx Elio Tissue Complete – An Automated and FDA-Approved Clinical Genomics Assay for Comprehensive Genomic Profiling of Human Cancer
PGDx Elio tissue complete, which the FDA has approved for the analysis of 505 cancer-related genes, will enable the development of more effective precision oncology treatment options. The researchers from Personal Genome Diagnostics Inc. (PGDx) explain the developmental and analytical validation processes of the PGDx elio tissue complete test. It is an automated NGS-based approach…